Drug-eluting stents for the prevention of restenosis: In quest for the holy grail

Saved in:

Bibliographic Details
Published in:	Catheterization and cardiovascular interventions Vol. 55; no. 3; pp. 409 - 417
Main Authors:	Hiatt, Bonnie L., Ikeno, Fumaiki, Yeung, Alan C., Carter, Andrew J.
Format:	Journal Article
Language:	English
Published:	New York Wiley Subscription Services, Inc., A Wiley Company 01-03-2002 Wiley-Liss
Subjects:	Animals Biological and medical sciences Cell Division - drug effects Clinical Trials as Topic Coated Materials, Biocompatible Coronary Restenosis - etiology Coronary Restenosis - prevention & control Dactinomycin - administration & dosage Depression, Chemical Diseases of the cardiovascular system Humans Infusion Pumps, Implantable Medical sciences Muscle, Smooth, Vascular - cytology Paclitaxel - administration & dosage Paclitaxel - pharmacology Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Sirolimus - administration & dosage Sirolimus - pharmacology Stents - adverse effects Endoprosthesis Sirolimus Coronary artery Instrumentation therapy Rabbit Instrumental dilatation Lagomorpha Macrolide Coated material Prevention Restenosis Vertebrata Mammalia Treatment Animal Complication Immunosuppressive agent
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	istex:6A5B469E8037ABF4CF794CDB1B675AEE756A1D26 ark:/67375/WNG-JQH9GFXM-1 ArticleID:CCD10161 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1522-1946 1522-726X
DOI:	10.1002/ccd.10161